Banner Default Image

Eleanor Fewings

Eleanor is a Senior Bioinformatics Scientist at Illumina. Her research interests focus on the relationship between germline (inherited) and somatic (acquired) mutations in the field of oncology. Eleanor completed her PhD in medical genetics at the University of Cambridge before moving to San Francisco to become more immersed in the biotech scene. There, during her Postdoctoral Fellowship, she published a joint first-author Nature paper on the genomic landscape of melanoma by utilising bioinformatics to identify mutations in individual healthy skin cells. More recently, Eleanor has worked generating tools for data-driven oncology drug discovery at Bayer. In 2022, she joined the Artificial Intelligence Lab at Illumina, continuing her research in the cancer genetics space.